Trelstar Powder For Suspension For Injection 22.5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Trelstar: Powder for suspension for injection (22.5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

TRIPTORELIN (TRIP toe rel in) decreases testosterone in men and estrogen in women. It is used to treat advanced prostate cancer and endometriosis.

In-Depth Information

Trelstar 22.5mg Powder for Injection

NDC: 525440092
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Prostate Cancer

Sometimes used for but not FDA approved for the following conditions:
Breast Cancer, Precocious Puberty, Endometriosis, Hirsutism, Infertility

Storage Information
Do not freeze
Store at controlled room temperature (between 68 and 77 degrees F)
Trelstar 22.5mg Powder for Injection

Reported Side Effects for Trelstar 22.5mg Powder for Injection

Pituitary Apoplexy Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Back Pain Incidence:
0.8-2.9%*
Severity: MILD
Onset: DELAYED
Inability To Sleep Incidence:
0.8-2.1%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
0.8-4.4%*
Severity: MODERATE
Onset: EARLY
Fluid Retention Incidence:
1.1%*
Severity: MODERATE
Onset: DELAYED
Muscle Pain Incidence:
1.1%*
Severity: MILD
Onset: EARLY
Retaining Urine Incidence:
1.1-1.4%*
Severity: MODERATE
Onset: EARLY
Loose Stools Incidence:
1.1-1.4%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
1.1%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
1.4%*
Severity: MILD
Onset: RAPID
Anemia Incidence:
1.4%*
Severity: MODERATE
Onset: DELAYED
Emotional Lability Incidence:
1.4%*
Severity: MILD
Onset: EARLY
Infection Incidence:
1.4%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
1.4-2.9%*
Severity: MILD
Onset: EARLY
Headache Incidence:
1.7-6.9%*
Severity: MILD
Onset: EARLY
Decreased Appetite Incidence:
1.7%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
1.7%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
1.7%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
1.7%*
Severity: MILD
Onset: EARLY
Gynecomastia Incidence:
1.7%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
2.1%*
Severity: MILD
Onset: EARLY
Tired Incidence:
2.1-2.3%*
Severity: MILD
Onset: EARLY
Decreased Sexual Desire Incidence:
2.3%*
Severity: MILD
Onset: DELAYED
Swelling Incidence:
2.3-6.3%*
Severity: MODERATE
Onset: DELAYED
Impotence (erectile Dysfunction) Incidence:
2.3-10.0%*
Severity: MODERATE
Onset: DELAYED
Joint Pain Incidence:
2.3%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
2.9%*
Severity: MILD
Onset: EARLY
Injection Site Reaction Incidence:
3.6-4.0%*
Severity: MILD
Onset: RAPID
Painful Urination Incidence:
4.6%*
Severity: MODERATE
Onset: EARLY
Testicular Atrophy Incidence:
7.5%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Bone Pain Incidence:
12.0%*
Severity: MODERATE
Onset: DELAYED
Muscle And/Or Bone Pain Incidence:
12.1-13.2%*
Severity: MILD
Onset: EARLY
Hot Flashes Incidence:
58.6-73.0%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

SECOND Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

THIRD Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Trelstar

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5